Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 February 2020 | Story Lacea Loader

During meetings between the management of the University of the Free State (UFS) and the Bloemfontein Campus Student Representative Council (CSRC) the week of 27 January 2020, an agreement regarding accredited and non-accredited accommodation was reached. Although it has been communicated to students on the university’s campuses earlier this week, it is important to clarify the agreement: 

• For 2020, students on the three campuses of the UFS who receive funding from the National Student Financial Aid Scheme (NSFAS) and who live in accredited and non-accredited accommodation, will receive the monthly accommodation allowance that will be paid directly into the student’s bank account.  Please note that the matter of the lease agreement is between the student and the service provider and the UFS does not take responsibility for payments to any supplier. The payments will only be made once funds are received from NSFAS.  

• Registered NSFAS beneficiaries must log in on Self Service and apply online for the private accommodation allowance. The application process requires that the lease agreement should be uploaded on the Self-Service portal. This lease agreement must be signed by both the student and the service provider. 

• Approved private accommodation applicants will receive their private accommodation allowance payment during the first week of each month for a period of 10 months, depending on the date of approval and the rental period.

• If the service provider does not have a lease agreement, students can download a basic lease agreement form here. This form must be signed by the student and the service provider.

• A process will be in place to verify the accommodation during 2020, as required by the Department of Higher Education, Science and Technology (DHET).  This process will start with the completion of the application form for accreditation by the service provider.  The application form can be obtained here.



News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept